Interactions between variants or variants-clinical variables and the binding stability of miRNAs to target ERBB4 gene sequence changing may be the mechanisms by which ERBB4 gene variants affect the susceptibility of pregnant women to GDM. This evidence concerns the gene ERBB4 and gestational diabetes.